Le Lézard
Classified in: Health, Science and technology, Business
Subject: TNM

Arjo and Bruin Biometrics conclude distribution agreement, Bruin Biometrics resumes direct sales and marketing of Provizio® SEM Scanner


LOS ANGELES and LONDON, Nov. 6, 2024 /PRNewswire/ -- Today Bruin Biometrics and Arjo announce the immediate transition of direct sales and marketing of the Provizio® SEM Scanner to Bruin Biometrics, following four years of cooperation between the companies.

Provizio® SEM Scanner

As communicated earlier this year, the companies decided not to extend the distribution agreement for the Provizio SEM Scanner. Accordingly, and effective today, all sales and marketing of the Provizio SEM Scanner products transition from Arjo to Bruin Biometrics. Both companies remain fully committed to supporting customers throughout the process to ensure a continued high level of customer service.

"Supporting Provizio SEM Scanner users' work to achieve a zero incidence of preventable pressure injuries in all care settings is our top priority and we look forward to supporting Provizio SEM Scanner users directly to help overcome this challenge," commented Bruin Biometrics' CEO, Martin Burns.

"Pressure injuries represent a significant economic challenge for healthcare systems worldwide, and Arjo has extensive experience in both prevention and treatment within this area. We see a growing interest for our other solutions and are fully committed to continue supporting our customers in their efforts to prevent pressure injuries," says Joacim Lindoff, President & CEO of Arjo.

For more information about Bruin Biometrics, please contact:
Kate Hancock, EVP External Communications, Bruin Biometrics Tel: +447827315347
Email: [email protected]

Media contact details:
Joanna Dodd, Alicia Barkle Rochester PR Group: [email protected], [email protected] 

ABOUT Bruin Biometrics

Bruin Biometrics LLC is a pioneer in modernizing healthcare with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians. Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles, USA.

BBI Logo.

Photo - https://mma.prnewswire.com/media/2549409/Provizio_SEM_Scanner.jpg
Logo - https://mma.prnewswire.com/media/3604/BRUIN_BIOMETRICS1__LLC_LOGO.jpg


These press releases may also interest you

at 15:30
Anthony "Tony" Van Heugten, the Chief Technology...

at 15:05
Merck , known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial evaluating zilovertamab vedotin, Merck's investigational antibody drug conjugate (ADC) that targets...

at 15:00
AbbVie announced groundbreaking results today from its latest Emotional Impact Report (EIR), a patient survey that provides an understanding of the mental...

at 15:00
SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., presented data at the American Epilepsy Society (AES) Annual Meeting, showcasing its antiseizure...

at 12:55
Vertex Pharmaceuticals Incorporated today announced longer-term data for CASGEVYtm (exagamglogene autotemcel) from global clinical trials in people with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the...

at 12:35
Kite, a Gilead Company , today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory (R/R) large B-cell lymphoma (LBCL), which were...



News published on and distributed by: